Clinical Laserthermia Systems AB (publ) (STO:CLS.B)
2.985
+0.150 (5.29%)
May 14, 2025, 5:22 PM CET
STO:CLS.B Revenue
In the year 2024, Clinical Laserthermia Systems AB had annual revenue of 18.78M SEK with 127.04% growth. Clinical Laserthermia Systems AB had revenue of 4.61M in the quarter ending December 31, 2024, with 3.50% growth.
Revenue
18.78M
Revenue Growth
+127.04%
P/S Ratio
3.87
Revenue / Employee
1.10M
Employees
17
Market Cap
72.64M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 18.78M | 10.51M | 127.04% |
Dec 31, 2023 | 8.27M | 2.01M | 31.99% |
Dec 31, 2022 | 6.27M | 4.02M | 179.20% |
Dec 31, 2021 | 2.25M | 913.00K | 68.54% |
Dec 31, 2020 | 1.33M | -4.17M | -75.79% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.24B |
Sectra AB | 3.30B |
Getinge AB | 35.57B |
Medicover AB | 23.56B |
Camurus AB | 1.87B |
AddLife AB | 10.42B |
Vitrolife AB | 3.61B |
Elekta AB | 17.88B |